Martin Tallman
MD
Chief, Leukemia Service
👥Biography 个人简介
Martin Tallman has led landmark clinical trials in acute myeloid leukemia spanning four decades. He played a key role in establishing ATRA-based therapy for APL and has been principal investigator on trials evaluating CPX-351 in secondary AML. He has served on multiple international guideline committees for AML management and is recognized for his contributions to improving remission rates in elderly AML patients.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Martin Tallman 的研究动态
Follow Martin Tallman's research updates
留下邮箱，当我们发布与 Martin Tallman（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment